China CYTS Tours:Growth slowing down and no catalyst ahead,d/g to Hold

类别:公司研究 机构:德意志银行 研究员:Tallan Zhou,Karen Tang 日期:2017-10-11

All lines miss, disappointing 1H17results

    CYTS's core earnings were flat in 1H17, while its top line was down 4.3% yoy. Thisis below consensus and our expectations. While Wuzhen and Gubei sustaineddouble-digit growth in both earnings and top line, exhibition business revenue/earnings fell 17%/30% yoy. We adjust down our full-year 2017core earnings by17% and 2018earnings by 19% on the back of the earnings miss. In addition,as we believe the exhibition business is unstable and unpredictable, we reduceour growth assumption for this business in 2017to negative 17%, from 12%previously. We downgrade CYTS to Hold with a new target price of RMB20, downfrom RMB26previously.

    Gubei's growth trend starting to slow down

    Gubei Town's total traffic in 1H17was 1.2million, up 28% yoy. Total revenue wasRMB434m , up 43% yoy. We believe Gubei's highest traffic growth was seen lastyear, at 56% yoy. Given that total tourist traffic is approaching total capacity, webelieve growth will be driven more by ASP than by tourist traffic. With our 2017Etraffic growth of 30% yoy unchanged, we now forecast 2017E ASP growth of11.5% yoy (vs. previous 8%) to match its 1H17ASP growth (11.5%).

    Wuzhen traffic seems to have reached a bottleneck

    Wuzhen Town's total traffic in 1H17was 5.12million, up 7.28% yoy. Totalrevenue was RMB784m, up 11.4% yoy. We believe Wuzhen's traffic is alreadyapproaching its bottleneck, which we estimate to be c. 10million every year.ASP changes will largely depend on total hotel room capacity in the West Zone(more people choosing to stay there should lift the ASP mix). We now forecastWest Zone 2017E traffic growth of 6%, vs. our previous 15%, to reflect a trafficslowdown in 1H17(+7.7% yoy in 1H17vs. +17% yoy in 1H16).

    Downgrading to Hold on rich valuation

    We derive our target price from a DCF-based valuation. Our key assumptionsremain unchanged, with a WACC of 8.1%, beta of 0.91, CoE of 9.0%, and terminalgrowth rate of 3%. We believe the current risk/reward profile for CYTS is notjustified. CYTS is trading at 32x/27x our 2017/18E PER, which we believe isrich given its slowing growth (its peers average 26x/21x 2017/18E PER). Keyupside risks include faster-than-expected growth of travellers. Key downside risksinclude a tourism industry slowdown and delays/uncertainties in ancient townnew projects. See page 5for details.

股票代码 股票名称 最新价(元) 涨跌额(元) 涨跌幅(%) 成交额(万元) 成交量(手)
600138 @nn@ @n@ @c@ @cc@ @v@ @t@

数据推荐

投资评级

更多>>
股票名称最新评级目标价研报
中信银行 买入 -- 研报
建设银行 持有 -- 研报
农业银行 买入 -- 研报
常熟银行 买入 -- 研报
招商银行 买入 -- 研报
宁波银行 买入 -- 研报
平安银行 买入 -- 研报
康龙化成 中性 -- 研报
泰格医药 中性 -- 研报
至纯科技 买入 26.50 研报
宝信软件 持有 -- 研报

盈利预测

评级选股>>
股票名称11年EPS12年EPS研报
千金药业 0.36 0.41 研报
迈克生物 0 0 研报
中国医药 0.76 1.06 研报
仙琚制药 0.42 0.50 研报
华海药业 0.44 0.56 研报
通策医疗 0.45 0.58 研报
新华制药 0.17 0.35 研报
华东医药 0.92 1.10 研报
济川药业 0 0 研报
华兰生物 1.01 0.74 研报
一心堂 0 0 研报

股票关注度

更多>>
股票名称关注度平均评级最新评级
贵州茅台 35 持有 买入
万科A 34 买入 中性
五粮液 34 持有 买入
中信证券 33 持有 买入
海天味业 30 持有 买入
三一重工 27 持有 买入
通威股份 27 持有 买入
伊利股份 27 持有 持有
隆基股份 26 买入 买入
万科A 26 买入 中性
泸州老窖 26 持有 买入
格力电器 26 持有 买入
中信证券 25 持有 买入
格力电器 25 持有 买入
保利地产 24 买入 中性
上汽集团 24 持有 买入
首旅酒店 24 持有 买入

行业关注度

更多>>
行业名称关注度关注股票数买入评级数
电子信息 555 95 329
建筑建材 500 48 210
化工行业 448 53 150
钢铁行业 442 30 210
金融行业 383 32 136
机械行业 378 49 162
汽车制造 377 38 203
生物制药 323 53 224
家电行业 315 17 156
电子器件 308 52 181
交通运输 299 30 137
煤炭行业 294 30 148
房地产 273 27 170
酿酒行业 251 17 124
电力行业 225 32 94
农林牧渔 189 28 74
酒店旅游 187 19 72